DEF 14AGRICIK 0001824293

GRI Bio, Inc.

Name: SEC EDGAR filing 0001824293-26-000060
Creator: GRI Bio, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed September 28, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Open the filing on SEC.gov

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001824293-26-000060
Filer: GRI Bio, Inc.
Ticker: GRI
CIK: 0001824293
Form type: DEF 14A
Form description: Proxy statement
Filed at: September 28, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 29, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1824293/000182429326000060/0001824293-26-000060-index.htm ↗

Filer's full EDGAR submission history

EDGAR · GRI Bio, Inc. (0001824293) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001824293-26-000060.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.